What is Lexicon Pharmaceuticals's financing cash flow?

Lexicon Pharmaceuticals (LXRX) reported financing cash flow of $88.76M in Q1 2026.

How has Lexicon Pharmaceuticals's financing cash flow changed year-over-year?

Lexicon Pharmaceuticals's financing cash flow increased by 15616.8% year-over-year, from -$572K to $88.76M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Lexicon Pharmaceuticals LXRX Financing Cash Flow

Financing Cash Flow at other companies

Eli LillyLLY

-$3.47B-351%

PfizerPFE

-$2.86B+45.4%

Merck & Co.MRK

-$2.98B+48.2%

Vertex PharmaceuticalsVRTX

-$538.8M+20.8%

CytokineticsCYTK

$7.77M+63.4%

Zevra Therapeutics, Inc.ZVRA

-$52.8M-3,386%

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+273%

Enterprise value$976.73M+219%

P/S14.2×+5.7×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's financing cash flow?: Lexicon Pharmaceuticals (LXRX) reported financing cash flow of $88.76M in Q1 2026.
How has Lexicon Pharmaceuticals's financing cash flow changed year-over-year?: Lexicon Pharmaceuticals's financing cash flow increased by 15616.8% year-over-year, from -$572K to $88.76M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.